Investigated for use/treatment in cardiovascular disorders, congestive heart failure, infertility, peripheral vascular disease, and scleroderma.

Investigated for use/treatment in spinal cord injuries.

Investigated for use/treatment in prostate cancer.

For use/treatment in osteoporosis.

Investigated for use/treatment in autoimmune diseases and inflammatory disorders (unspecified).

Investigated for use/treatment in liver disease.

Investigated for use/treatment in breast cancer.

Investigated for use/treatment in anthrax exposure and bacterial infection.

Investigated for use/treatment in HIV infection.

Investigated for use/treatment in heart disease and myocardial infarction.

Investigated for use/treatment in diabetes mellitus type 2.

Used in patients 4 years of age and older to treat Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS), which are both part of the Cryopyrin-Associated ...

Ipilimumab is indicated for the treatment of unresectable or metastatic melanoma in adults.

Thrombopoietin receptor agonists are pharmaceutical agents that stimulate platelet production in the bone marrow. In this, they differ from the previously discussed agents that act...

For the treatment of hypercalcemia associated with malignant disease.

Indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more Disease-Modifying ...

Pertuzumab is indicated for use in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior ...

Investigated for use/treatment in HIV infection.

Dalfampridine is a neurofunctional modifier that helps improve walking speed in patients with multiple sclerosis (MS).

Prolia is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture. It reduces the incidence of vertebral, nonvertebral, and hip fractures. ...